The Health Research Ethics Act repeals the prior Health Research Ethics Authority Act and restates provincial rules for oversight of health research. It recasts the authority’s objects, adjusts governance of the authority and research ethics board, and creates a formal pathway for certain minimal‑risk studies approved by specified external bodies to proceed in the province without repeat review.
Practically, the Act sets concrete composition requirements for both the authority and the research ethics board (including a required privacy‑knowledgeable member and a gender‑diversity consideration), prescribes application, referral and review timelines, requires monitoring and close‑out reporting, revises reconsideration and appeal procedures to mirror Tri‑Council practices, and imposes graduated monetary penalties for noncompliance. The Act also contains transitional rules, an audit requirement, and a July 1, 2025 commencement date.
At a Glance
What It Does
The Act continues the Health Research Ethics Authority as a corporate body, mandates minimum membership and expertise on the research ethics board, requires applicants to submit to the authority which must refer completed applications within two business days, and permits minimal‑risk studies approved by competent external Canadian bodies to proceed with notification and a fee. It centralizes monitoring, suspension and cancellation powers and establishes an internal appeal panel whose decisions can be taken to the Supreme Court.
Who It Affects
Researchers and principal investigators working with human participants, hospitals and universities that host or sponsor research, institutional privacy officers and legal counsel, provincial research ethics bodies seeking approval, and the Authority itself which gains operational responsibilities. Licensing bodies and employers also are pulled into enforcement where breaches implicate regulated professionals or unlicensed persons.
Why It Matters
The Act reduces duplication for minimal‑risk research by recognizing external approvals, but also tightens provincial oversight with defined timelines, monitoring powers, mandatory notification and fees. That shifts practical compliance work (and some costs) onto researchers and local institutions while creating new verification and administrative duties for the Authority.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Act preserves a single provincial authority to oversee ethics review and creates a clearer rulebook for how research gets reviewed, monitored and enforced. It requires applicants to submit applications to the Authority, which must pass a completed file to either the provincial research ethics board or an approved research ethics body within two business days.
Once referred, a review body has thirty days to act: approve, approve with conditions, or refuse. In choosing standards, review bodies must apply the Tri‑Council Policy Statement, the ICH E6 Good Clinical Practice guidance, or other Authority‑approved standards, and can—subject to Authority approval—vary or substitute standards when appropriate.
For minimal‑risk projects, the Act allows an exception to repeat review: if a project already received approval from a defined “competent Canadian research ethics body” or another prescribed body, the investigator need not obtain fresh approval in Newfoundland and Labrador. Instead the investigator must notify the Authority in the prescribed form and pay a fee.
The Act sets out who qualifies as a competent external body by minimum composition and affiliation criteria, and authorizes the minister to prescribe additional bodies by regulation.The Act strengthens oversight tools: the approving review body may monitor projects, inspect records and premises, suspend projects pending correction of deficiencies, or cancel projects for specified reasons. Principal investigators must submit a close‑out report at the end of a project prepared to Authority requirements.
Where investigators dispute a decision, they first seek reconsideration by the reviewing body; unresolved cases go to an appeal board drawn from an Authority‑appointed appeal panel. Appeal board decisions are written with reasons and are binding on the parties, though they may be appealed to the Supreme Court within 30 days.Governance and administrative details are specific.
The Authority comprises seven directors with a mix of government, university, health authority and public representatives; the chair of the research ethics board sits as a non‑voting director. The research ethics board must have at least ten members and include specified expertise (research experience, ethics, law, privacy and a public representative), and the Authority must consider gender diversity when appointing members.
The Act also establishes annual budgeting, audits by the Auditor General, reimbursement rules, indemnities for good‑faith actors, and civil penalties for noncompliance ranging from $5,000–$50,000 on first conviction to $10,000–$100,000 on subsequent convictions. Transition provisions preserve existing approvals and memberships until terms expire.
The Five Things You Need to Know
The Authority must refer a completed application to a research ethics board or approved research ethics body within two business days of receipt.
Research ethics boards must have at least 10 members and include persons knowledgeable in ethics, law, privacy, research experience and at least one public representative.
Minimal‑risk health research approved by a ‘competent Canadian research ethics body’ or a body prescribed by regulation does not require new approval in the province, but investigators must notify the Authority and pay a fee.
Appeals follow a two‑tier internal process: reconsideration by the reviewing body, then an appeal to a five‑member appeal board drawn from an Authority‑appointed panel; appeal board decisions are binding but can be brought to the Supreme Court within 30 days.
Offences carry summary conviction fines: $5,000–$50,000 for a first conviction and $10,000–$100,000 for subsequent convictions.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Authority structure and director composition
Section 4 continues the Health Research Ethics Authority as a corporation and fixes its board at seven directors: specific appointees from Memorial University, the Provincial Health Authority, the minister’s department, three public representatives, and the chair of the research ethics board as a non‑voting director. The minister appoints the chair of the Authority after consulting the university and health authority. The provision creates staggered term rules (three‑year terms, nine‑year maximum consecutive service) and sets the mechanics for mid‑term replacements. For operational planning this clause makes clear who controls appointments and the maximum tenure, which matters for institutional relationships and long‑run governance continuity.
Research ethics board composition and appointment rules
Section 8 requires the Authority, after consultations, to appoint a research ethics board with no fewer than ten members and directs selection according to Tri‑Council principles. It specifies minimum roles: two experienced researchers, at least one ethics expert, one legal expert (distinct from institutional counsel), one privacy‑knowledgeable person and one public representative; it also requires the Authority to consider gender diversity. It sets the chair selection process (majority vote of board members), term lengths (up to three years, nine‑year cap) and permits the board to make by‑laws with Authority approval. These mechanics limit institutional capture by ensuring external and privacy expertise and create a formal route for the board to self‑govern within Authority parameters.
Application, referral, review timelines and minimal‑risk pathway
Section 10 makes approval from the research ethics board or an approved research ethics body a statutory prerequisite for health research and requires applicants to submit to the Authority along with an application fee. The Authority must forward completed applications to a review body within two business days, and the reviewer must reach a decision within 30 days. Section 11 creates an important carve‑out: investigators whose minimal‑risk studies received approval from a ‘competent Canadian research ethics body’ or a prescribed body may proceed without provincial approval but must notify the Authority and pay a fee. The Act defines the minimum composition and affiliation for a competent external body and gives the minister regulatory authority to add prescribed bodies, establishing a predictable but administrable acceptance route for external reviews.
Monitoring, suspension, cancellation and close‑out reporting
Section 13 gives the approving review body authority to monitor projects, inspect records and premises, and to suspend or cancel projects where methodology, record keeping, participant conduct or other regulatory deficiencies arise. The board may suspend pending correction or cancel for specified or regulation‑prescribed reasons. Section 14 instructs principal investigators to file a close‑out report with both the Authority and the approving body in an Authority‑specified format. Together these provisions convert approval into an ongoing compliance regime, create inspection rights and establish a formal project termination documentation requirement.
Reconsideration and appeals aligned with Tri‑Council approach
Sections 15–20 set out a layered dispute resolution process: a dissatisfied principal investigator may seek reconsideration from the approving body, present written or oral submissions, and then, if still dissatisfied, appeal to an appeal board composed of five members from an Authority‑appointed panel. Appeal boards must give full hearing to the parties, issue written decisions with reasons, and their determinations are binding on the parties; those decisions can be judicially reviewed or appealed to the Supreme Court within 30 days. The appointment rules for the appeal panel (three‑year terms, nine‑year cap, ineligibility to sit as directors or board members) aim to preserve impartiality and expertise in appeals.
Advisory committee composition and annual meetings
Section 21 authorizes the minister, after consulting the Authority, to appoint an advisory committee with broad representation (regional, Indigenous, health professionals, institutional representatives, researchers and public members). The committee is to meet with the Authority and research ethics board at least annually to discuss ethics governance and research conduct. The clause institutionalizes stakeholder input and specifically requires Indigenous representation, although it leaves size and selection details to practical implementation.
Budgeting, audit, indemnities, penalties and commencement
These sections create standard administrative guardrails: the Authority must prepare an annual budget for ministerial approval, is audited annually by the Auditor General, and must adhere to expenditure limits. Chairpersons receive compensation; other board members serve without remuneration but may be reimbursed. Section 27 provides indemnities for good‑faith actors. Section 31 prescribes summary conviction fines ranging from $5,000 to $50,000 for first offences and $10,000 to $100,000 for subsequent offences. Section 36 sets the Act’s coming‑into‑force date as July 1, 2025, and transitional provisions preserve existing approvals and memberships until terms expire to avoid immediate program disruption.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Principal investigators conducting minimal‑risk studies — they can avoid repeat full provincial review if they hold approval from a competent external Canadian research ethics body, reducing duplicative review and accelerating project starts, subject to notification and fee requirements.
- Institutions with robust REBs (universities and large hospitals) — their approvals gain portability into Newfoundland and Labrador when their REBs meet the statutory competence criteria, which simplifies multi‑jurisdictional research collaborations.
- Privacy experts and public representatives — the statutory requirement for privacy knowledge and a public member on the REB increases the influence of privacy and lay perspectives in decisions and board deliberations.
- Indigenous communities (Labrador Inuit) — the Act explicitly requires provincial application consistent with the Labrador Inuit Land Claims Agreement and calls for Indigenous representation on the advisory committee, giving formal recognition to local Indigenous rights and input in research governance.
- Research participants and the public — stronger monitoring powers, suspension and cancellation authorities, mandatory close‑out reporting and Auditor General audits increase transparency and the potential for consistent oversight of participant protections.
Who Bears the Cost
- Health Research Ethics Authority — the Authority must establish processes to triage applications within tight timelines, verify competence of external bodies, administer notifications and fees, support monitoring and appeals, and manage annual budgeting under ministerial approval, creating administrative and staffing burdens.
- Researchers and sponsoring institutions — while minimal‑risk portability can save time, investigators still must pay application or notification fees, prepare Authority‑specified documentation and close‑out reports, and respond to monitoring reviews, increasing compliance workloads and potential costs.
- Smaller or non‑accredited research ethics bodies — to be approved a body must meet the Act’s criteria and Authority standards, which may require investment in governance, membership and procedural upgrades to qualify as an accepted reviewer.
- Licensing bodies and employers — when regulated professionals breach the Act the matter is referred to licensing bodies; where participants are not regulated, employers receive noncompliance reports, shifting enforcement costs and reputational risks to third parties.
- Provincial government finances — ministerial oversight, audits and potential tribunal or court appeals may generate costs; unless the Authority receives adequate funding, operational obligations could strain existing budgets.
Key Issues
The Core Tension
The central tension is between reducing administrative barriers for low‑risk research by accepting external approvals and maintaining a consistent, enforceable standard of participant protection within the province: streamlining promotes research throughput and inter‑jurisdictional collaboration, but it forces the Authority to trust—or rigorously verify—external ethics processes, exposing the province either to duplicative work (if verification is strict) or to potential inconsistencies in participant protections (if verification is lax).
The Act creates a practical trade‑off between reducing duplicative ethics review and preserving consistent participant protections. Accepting approvals from external ‘competent’ REBs speeds research but places an evidentiary burden on the Authority to verify competence and on investigators to supply adequate notification materials; the statutory competence criteria are specific but discretionary regulatory additions could expand or contract which bodies qualify.
That verification task is operationally heavy: the Authority will need policies, staff and possibly external advisors to assess whether an external body’s processes truly comport with Tri‑Council standards in practice, not just on paper.
The Act also leaves notable implementation choices to regulations and the Authority: the specifics of application fees and notification forms, any additional prescribed bodies for the minimal‑risk pathway, what constitutes ‘‘other reasons’’ to cancel a project, and the Authority’s standard for substituting or varying Tri‑Council provisions. Those delegated authorities can produce divergent practice across jurisdictions or over time if not tightly specified.
Finally, the penalties are significant for summary offences and may have a chilling effect on small‑scale researchers or community‑led projects unless paired with clear guidance and graduated enforcement. The Labrador Inuit Land Claims Agreement override clause recognizes Indigenous precedence where conflicts arise, but the mechanics for operationalizing consent, review expectations or culturally specific safeguards remain undefined in the Act itself.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.